好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2005 Annual Meeting | Update in Neurology I

Sunday 04/10/05
09:00 AM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Full-Day Course
Ralph F. Jozefowicz, MD, FAAN
General Neurology/Neurology of Systemic Disease
Upon completion:
Participants should be able to recognize and treat the common headache syndromes; recognize the important neuro-ophthalmologic disorders seen in neurology practice; diagnose and manage the common neurological problems seen in patients with general medical illnesses; utilize the newest disease modifying treatments for multiple sclerosis; diagnose and treat the major causes of dizziness; appropriately diagnose and treat patients presenting with spine and back disorders; offer patients with cancer of the nervous system the best evidence-based treatment options; and apply evidence-based approaches to the treatment and prevention of stroke.

The American Board of Psychiatry and Neurology has reviewed Update in Neurology I and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.
No CME available
Advanced
Practitioner, Fellow, Academician, Resident
Event Timeline
09:00 AM - 09:45 AM Update in Headache
Peter Goadsby, MD, PhD, FRS
09:45 AM - 10:30 AM Update in Neuro-ophthalmology
Nancy J. Newman, MD, FAAN
10:30 AM - 10:45 AM Break
10:45 AM - 11:30 PM Update in Multiple Sclerosis
Patricia K. Coyle, MD, FAAN
11:30 AM - 12:15 PM Update in Medical Neurology
Martin A. Samuels, MD, MACP, FAAN
12:15 PM - 01:30 PM Lunch
01:30 PM - 02:15 PM Update in Dizziness
Robert W. Baloh, MD, FAAN
02:15 PM - 03:00 PM Update in Spine Disorders
J. D. Bartleson, MD, FAAN
03:00 PM - 03:15 PM Break
03:15 PM - 04:00 PM Update in Neuro-oncology
Amy A. Pruitt, MD, FAAN
04:00 PM - 05:00 PM Update in Stroke
David L. Gordon, MD, FAHA, FANA, FAAN
Faculty Disclosures
Robert W. Baloh, MD, FAAN No disclosure on file
J. D. Bartleson, MD, FAAN Dr. Bartleson has nothing to disclose.
Patricia K. Coyle, MD, FAAN Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Company. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Coyle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Coyle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Coyle has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Celgene.
Ralph F. Jozefowicz, MD, FAAN Dr. Jozefowicz has nothing to disclose.
Nancy J. Newman, MD, FAAN Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophth. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Newman has received research support from GenSight. The institution of Dr. Newman has received research support from Santhera. The institution of Dr. Newman has received research support from NINDS/NIH. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
Amy A. Pruitt, MD, FAAN Dr. Pruitt has nothing to disclose.
Martin A. Samuels, MD, MACP, FAAN No disclosure on file
David L. Gordon, MD, FAHA, FANA, FAAN Dr. Gordon has nothing to disclose.
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli-Lilly. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aurene. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon Biopharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. The institution of Dr. Goadsby has received research support from Kallyope. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Executive roles with American Headache Society that is relevant to AAN interests or activities.